|
Bieżący numer
Archiwum
O czasopiśmie
Rada naukowa
Recenzenci
Bazy indeksacyjne
Kontakt
Zasady publikacji prac
Opłaty publikacyjne
Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
|
2/2023
vol. 8 Artykuł oryginalny
Wybrane parametry krwi o potencjalnie diagnostycznym zastosowaniu w przebiegu stanu zapalnego u osób przewlekle otyłych poddanych operacji bariatrycznej
Marietta Bracha
1
 ,
Małgorzata Szady-Grad
2
Long-Term Care Nursing 2023; 8 (2): 39-45
Data publikacji online: 2023/06/29
Plik artykułu:
- 4.pdf
[0.08 MB]
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
1. WHO Fact Sheet: Obesity and overweight. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight Dostęp 30.04.2023 2.
World Obesity Day 2022 – Accelerating action to stop obesity. Available at: https://www.who.int/news/item/04-03-2022-world-obesity-day-2022-accelerating-action-tostop-obesity Dostęp 30.04.2023 3.
Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 14: 860-7 4.
Biobaku F, Ghanim H, Monte SV, Caruana JA, Dandona P. Bariatric Surgery: Remission of Inflammation, Cardiometabolic Benefits, and Common Adverse Effects. J Endocr Soc 2020; 4; 4(9). 5.
Ellulu MS, Patimah I, Khaza’ai H, i in. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci 2017; 13(4): 851–63. 6.
Goralska M, Majewska-Szczepanik M, Szczepanik M. Mechanizmy immunologiczne towarzyszące otyłości i ich rola w zaburzeniach metabolizmu. Postępy Higieny i Medycyny Doświadczalnej 2015; 69: 1384-1404. 7.
Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity 2022: 55.1: 31-55. 8.
Scheithauer, Torsten PM, i in. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Frontiers in immunology 2020; 2546. 9.
Ferraz-Bannitz R, Welendorf CR, Coelho PO, i in. Bariatric surgery can acutely modulate ER-stress and inflammation on subcutaneous adipose tissue in non-diabetic patients with obesity. Diabetol Metab Syndr 2021; 13(1): 1-11 10.
Sacks FM, Bray GA, Carey VJ, i in. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. Obstet Gynecol Surv 2009; p. 460–2. 11.
Caudwell P, Hopkins M, King NA, Stubbs RJ, Blundell JE. Exercise alone is not enough: weight loss also needs a healthy (Mediterranean) diet? Public Health Nutr 2009; 12(9A): 1663-6. 12.
Velazquez A, Apovian CM. Pharmacological management of obesity. Minerva Endocrinol. 2018; 356–66. 13.
Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol 2017; 160–9. 14.
Fred M, Heiner V, Basdevant A, i in. Wytyczne europejskie w zakresie chirurgicznego leczenia otyłości olbrzymiej. Endokrynol Otył Zab Przem Mat 2009; 5: 9. 15.
Kuczyńska B, Biczysko M, Bogdański P. Chirurgiczne leczenie otyłości olbrzymiej i zaburzeń metabolicznych. Forum Zaburzeń metabolicznych 2012; 3(2); 61-69. 16.
Welbourn R, Hollyman M, Kinsman R, i in. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg 2019; 29(3): 782–95. 17.
Forsythe LK, Wallace JM, Livingstone MB. Obesity and inflammation: the effects of weight loss. Nutr Res Rev 2008; 21 :117–133. 18.
Askarpour M, Khani D, Sheikhi A, i in. Effect of Bariatric Surgery on Serum Inflammatory Factors of Obese Patients: a Systematic Review and Meta-Analysis. Obes Surg 2019; 29: 2631–2647. 19.
Lautenbach A, Stoll F, Mann O, i in. Long-term improvement of chronic low-grade inflammation after bariatric surgery. Obes Surg 2021; 5: 1–8. 20.
Huang J, Chen Y, Wang X, i in. Change in Adipokines and Gastrointestinal Hormones After Bariatric Surgery: a Metaanalysis. Obes Surg 2023; 33: 789–806 21.
El-Zawawy HT, El-Aghoury AA, Katri K M, i in. Cortisol/DHEA ratio in morbidly obese patients before and after bariatric surgery: Relation to metabolic parameters and cardiovascular performance. Int J Obes 2022; 46: 381–392. 22.
Oliveras A, Molina L, Goday A, i in. Effect of bariatric surgery on cardiac structure and function in obese patients: Role of the renin‐angiotensin system. The Journal of Clinical Hypertension 2021; 23(1): 181-192. 23.
Netto BDM, Bettini SC, Clemente APG, i in. Roux-en-Y gastric bypass decreases proinflammatory and thrombotic biomarkers in individuals with extreme obesity. Obes Surg 2015; 25: 1010–8. 24.
Masquio DC, de Piano A, Sanches PL, i in. The effect of weight loss magnitude on pro-/anti-inflammatory adipokines and carotid intima-media thickness in obese adolescents engaged in interdisciplinary weight loss therapy. Clin Endocrinol 2013; 79(1): 55–64. 25.
Sachan A, Singh A, Shukla S, i in. An immediate post op and follow up assessment of circulating adipo-cytokines after bariatric surgery in morbid obesity. Metabolism Open 2022; 13: 100147. 26.
Tabasi M, Eybpoosh S, Siadat SD, i in. Modulation of the gut microbiota and serum biomarkers after laparoscopic sleeve gastrectomy: a 1-year follow-up study. Obes Surg 2021; 31(5): 1949–56. 27.
Carmona-Maurici J, Cuello E, Ricart-Jane D, i in. Effect of bariatric surgery on inflammation and endothelial dysfunction as processes underlying subclinical atherosclerosis in morbid obesity. Surg Obes Relat Dis 2020; 16(12): 1961–70. 28.
Schmatz R, Bitencourt MR, Patias LD, i in. Evaluation of the biochemical, inflammatory and oxidative profile of obese patients given clinical treatment and bariatric surgery. Clin Chim Acta 2017; 465: 72-9. 29.
Villarreal-Calderon JR, Cuellar RX, Ramos-Gonzalez M, i in. Interplay between he adaptive immune system and insulin resistance in weight loss induced by bariatric surgery. Oxidative medicine and cellular longevity 2019. 30.
Tham JC, Howes N, le Roux CW. The role of bariatric surgery in the treatment of diabetes. Ther Adv Chronic Dis 2014; 5(3): 149–57.
|
ENGLISH
